The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Selective NLRP3-inflammasome inhibitor MCC950 Mitigates Post-resuscitation Myocardial Dysfunction and Improves Survival in a Rat Model of Cardiac Arrest and Resuscitation
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-01
DOI
10.1007/s10557-021-07282-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MCC950, a NLRP3 inhibitor, ameliorates lipopolysaccharide-induced lung inflammation in mice
- (2020) Lu Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- Pioglitazone Confers Neuroprotection Against Ischemia-Induced Pyroptosis due to its Inhibitory Effects on HMGB-1/RAGE and Rac1/ROS Pathway by Activating PPAR-ɤ
- (2018) Pingping Xia et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
- (2018) Emelia J. Benjamin et al. CIRCULATION
- MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury
- (2018) Saifudeen Ismael et al. JOURNAL OF NEUROTRAUMA
- Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke
- (2018) Saifudeen Ismael et al. Scientific Reports
- Effects of Polyethylene Glycol-20k on Postresuscitation Myocardial and Cerebral Function in a Rat Model of Cardiopulmonary Resuscitation
- (2018) Jin Yang et al. CRITICAL CARE MEDICINE
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats
- (2017) Zhen Qiu et al. Oxidative Medicine and Cellular Longevity
- Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia–reperfusion in the mouse
- (2016) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Role of NLRP3 (cryopyrin) in acute myocardial infarction
- (2013) Eleonora Mezzaroma et al. CARDIOVASCULAR RESEARCH
- Targeting Interleukin-1 in Heart Disease
- (2013) Benjamin W. Van Tassell et al. CIRCULATION
- Mechanisms of NOD-like Receptor-Associated Inflammasome Activation
- (2013) Haitao Wen et al. IMMUNITY
- The role of inflammation in postresuscitation myocardial dysfunction
- (2013) Zhe Wu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Postreanimationssyndrom
- (2012) A. Schneider et al. ANAESTHESIST
- Comparison of the Durations of Mild Therapeutic Hypothermia on Outcome After Cardiopulmonary Resuscitation in the Rat
- (2011) Sen Ye et al. CIRCULATION
- Post–Cardiac Arrest Syndrome
- (2008) Robert W. Neumar et al. CIRCULATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started